Strategic Partnership SpinTech MRI has recently announced a strategic collaboration with IMRIS to integrate STAGE neuro-imaging software into the IMRIS InVision surgical theater platform, signaling potential cross-sell opportunities to iMRI-enabled facilities and broader clinical workflows.

Imaging ROI STAGE advances scan speed and biomarker detection while remaining compatible with most manufacturers’ equipment, presenting a compelling value proposition for hospitals and imaging centers seeking to improve throughput and maximize MRI equipment ROI.

Clinical Reach The platform targets neurological conditions such as traumatic brain injury, dementia, Parkinson’s, MS, and stroke, suggesting sales emphasis toward neurology and neurorehabilitation departments, research centers, and multi-center trials seeking robust data and AI-assisted diagnosis.

Financial Footprint With annual revenue in the lower mid-range and a $6.5M Series A secured in 2022, SpinTech presents an agile, high-growth opportunity for medical device distributors and health systems investing in next-gen MRI software to differentiate offerings.

Growth Signals Funding history, award recognition, and recent acquisitions indicate a momentum-driven company readiness to scale, presenting a proactive window for outreach to strategic buyers, integrators, and digital health partners involved in neuro-imaging innovation.